Hypertrophic neuropathy of Dejerine-Sottas
Alternate names[edit | edit source]
Dejerine-Sottas syndrome; DSS; Charcot-Marie-Tooth Disease, type 3; CMT3; Hereditary motor and sensory neuropathy 3; HMSN3; Dejerine-Sottas neuropathy; DSN; Charcot-Marie-Tooth disease type 3; Hereditary motor and sensory neuropathy type 3; HMSN 3; Hypertrophic neuropathy of infancy; Hereditary motor and sensory neuropathy type III; HMSN III
Definition[edit | edit source]
Hypertrophic neuropathy of Dejerine-Sottas (Dejerine-Sottas syndrome) is a term sometimes used to describe a severe, early childhood form of Charcot-Marie-Tooth disease (sometimes called type 3) that is characterized by sensory loss with ataxia in the limbs furthest from the body and pes cavus with progression towards the limbs closest to the body.
Types[edit | edit source]
Depending on the specific gene that is altered, this severe, early onset form of the disorder may also be classified as type 1 or type 4.
Cause[edit | edit source]
Dejerine-Sottas syndrome has been associated with mutations in the MPZ, PMP22, EGR2, and PRX genes.
Inheritance[edit | edit source]
Autosomal dominant and autosomal recessive inheritance have been described.
Signs and symptoms[edit | edit source]
It is characterized by sensory loss with ataxia in the limbs furthest from the body and pes cavus with progression towards the limbs closest to the body.
Diagnosis[edit | edit source]
- On medical imaging, the nerves of the extremities (and cranial nerves in some cases) appear enlarged due to hypertrophy of the connective interstitial tissue, giving the nerves a distinct "onion-bulb" appearance.
- Peripheral (and possibly cranial) nerve excitability and conduction speed are reduced.
Treatment[edit | edit source]
management is based on sign and symptoms.
NIH genetic and rare disease info[edit source]
Hypertrophic neuropathy of Dejerine-Sottas is a rare disease.
Hypertrophic neuropathy of Dejerine-Sottas Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju